Topic: Astrazeneca Group

LONDON/PARIS (Reuters) - Three of Europe's biggest drugmakers -- AstraZeneca , Novartis and Sanofi -- reported product setbacks on Tuesday, underlining the difficulties of developing new medicines to make up for those going off patent.With the weakest pipeline of its European peers, ...

LONDON (Reuters) - AstraZeneca is cutting nearly a quarter of its U.S. sales force in a second wave of redundancies in as many months as it seeks to reduce costs.Britain's second biggest drugmaker said on Wednesday it would cut about 1,150 sales ...

LONDON (Reuters) - AstraZeneca is cutting nearly a quarter of its U.S. sales force in a second wave of redundancies in as many months as it seeks to reduce costs.Britain's second biggest drugmaker said on Wednesday it would cut about 1,150 sales ...

(Reuters) - A federal appeals court on Thursday refused to revive Teva Pharmaceutical Industries Ltd's patent infringement suit against AstraZeneca Pharmaceuticals LP for the rights to Crestor, a multibillion-dollar cholesterol fighter.In a ruling that upheld a lower court, the U.S. Court of ...

(Reuters) - AstraZeneca Plc said on Thursday it will cut about 400 jobs from its U.S. commercial business as Britain's second-largest drugmaker seeks to reduce costs.The cuts will hit the company's U.S. headquarters in Wilmington, Delaware, as well as some field-based, non-sales ...

(Reuters) - AstraZeneca went back to court on Wednesday to defend the U.S. patent on its multibillion-dollar cholesterol fighter Crestor in the face of an appeal by generic drugmakers.Industry analysts believe the British company is likely to win the case, protecting exclusivity ...

BOSTON (Reuters) - Targacept Inc, a small drugmaker that began life inside the bowels of R.J. Reynolds Tobacco Co, has for years been using its understanding of nicotine to develop experimental treatments for depression, schizophrenia and, yes, smoking cessation.Now it is poised ...

Anglo-Swedish pharmaceuticals giant AstraZeneca on Wednesday said it had agreed to sell its Astra Tech unit to US dental implant manufacturer Dentsply International for $1.8 billion (1.25 billion euros).The cash deal for the dental division, which is expected to complete this year ...

LONDON (Reuters) - In an industry first, drugmaker AstraZeneca is scrapping payments for doctors to attend international medical congresses.The move follows increased scrutiny of the $850 billion-a-year industry's potentially undue influence on prescribers and could put pressure on rivals to follow suit.AstraZeneca ...

LONDON (Reuters) - David Livermore is in a race against evolution. In his north London lab, he holds up an evil-smelling culture plate smeared with bacteria. This creamy-yellow growth is the enemy: a new strain of germs resistant to the most powerful ...